Inactive Instrument

Voluntis S.A.

ALVTX

FR0004183960

Voluntis S.A. Reports Earnings Results for the Full Year Ended December 31, 2020

March 30, 2021 at 01:48 pm EDT

Voluntis S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 5.189 million compared to EUR 4.672 million a year ago. Operating loss was EUR 11.103 million compared to EUR 14.827 million a year ago. Net loss was EUR 12.124 million compared to EUR 15.813 million a year ago.

Latest news about Voluntis S.A.

AptarGroup, Inc. completed the acquisition of remaining 35.4% stake in Voluntis S.A..	21-10-14	CI
Global markets live: Intel, Apple, Rolls-Royce, Raytheon, MGM...	21-09-27
Global markets live: Thales, Nestlé, Evergrande, AMC, Walmart...	21-09-16
Global markets live: Amazon, Delivery Hero, Walmart, Broadcom, JD.com, Didi Global...	21-09-03
AptarGroup : Completes Deal to Buy Nearly 65% of Voluntis; Mandatory Takeover Offer to Commence	21-09-03	MT
AptarGroup : Completes Acquisition of Majority Stake in Voluntis	21-09-02	MT
Voluntis S.A. Announces Executive Changes	21-09-02	CI
AptarGroup, Inc. made an offer to acquire remaining 35.4% stake in Voluntis S.A. for €27.4 million.	21-09-01	CI
AptarGroup, Inc. completed the acquisition of 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel.	21-09-01	CI
AptarGroup : Signs Deal to Buy Majority Stake in Digital Therapeutics Firm Voluntis for 8.70 Euros Per Share	21-07-26	MT
AptarGroup, Inc. signed a share purchase agreement to acquire 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel for €50.1 million.	21-07-22	CI
Linklaters Advises Aptar on Entering into Exclusive Negotiations Regarding A Potential Acquisition of Voluntis	21-06-30	CI
Voluntis Enters into Exclusive Negotiations with AptarGroup	21-06-22	CI
AptarGroup : Says in Exclusive Negotiations on Potential Acquisition of Voluntis	21-06-22	MT
Global markets live: Apple, Nvidia, Biogen, Fastly, Tilray...	21-06-08
Global markets live: Uber, AB Inbev, PayPal...	21-05-06
Global markets live: Tesla, UBS, Novartis...	21-04-27
Voluntis and Eisai to Collaborate on Digital Therapeutics for Oncology Patients	21-04-27	CI
Voluntis S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Broward Health and Voluntis Launch A New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast Cancer	21-03-18	CI
Voluntis : Changes Listing to Euronext Growth Paris From Euronext Paris	21-02-17	MT
Voluntis S.A.(ENXTPA:ALVTX) dropped from CAC Small Index	21-02-16	CI
Voluntis S.A.(ENXTPA:ALVTX) dropped from CAC All-Tradable Index	21-02-16	CI
Voluntis : Rises 5% on Receipt of European Patent for Drug Dosing Support Technology	21-02-15	MT
Voluntis : To Change Listing To Euronext Growth Paris; Shares Up 10%	21-02-15	MT

Chart Voluntis S.A.

Duration

Period

More charts

Company Profile

Voluntis SA is a France-based company specialized in medical solutions. The Company designs prescription applications that embed medical intelligence in the smart phones of people suffering from chronic and rare diseases. Voluntis SA develops digital solutions for diabetes, respiratory diseases, cancer, anticoagulation and hemophilia. Its product portfolio includes Insulia, a prescription-only medical device, which is a digital therapeutic for people with type 2 diabetes who are being treated with long-acting basal insulin. The medical device also provides patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; Theraxium platform, which is a flexible platform that transforms health data into medical intelligence, and Quality and Regulatory Expertise, which focuses on patient safety, among others.

Sector

Software

More about the company

Sector Application Software

	1st Jan change	Capi.
ADOBE INC.	-22.42%	212B
WORKDAY INC.	-11.35%	66B
ROPER TECHNOLOGIES, INC.	-6.18%	54.97B
AUTODESK, INC.	-12.58%	46.37B
DATADOG, INC.	+3.39%	43.14B
ELECTRONIC ARTS INC.	-7.30%	34.19B
ANSYS, INC.	-10.47%	28.8B
APPLOVIN CORPORATION	+77.09%	24.04B
PTC INC.	+1.42%	21.6B

Application Software